LMR Partners LLP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
LMR Partners LLP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$215,000
+150.0%
17,872
+34.3%
0.00%
+100.0%
Q3 2022$86,000
+41.0%
13,3070.0%0.00%
+100.0%
Q2 2022$61,000
-37.8%
13,307
-42.4%
0.00%
-50.0%
Q4 2020$98,000
+14.0%
23,093
-30.0%
0.00%0.0%
Q3 2020$86,000
-25.9%
32,9900.0%0.00%
-33.3%
Q2 2020$116,00032,9900.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders